Search Results 341-350 of 11734 for Drug-resistant TB
This medicine should be started at the same time as treatment with a luteinizing hormone-releasing hormone (LHRH) analog (eg, goserelin, leuprolide, Lupron®, or ...
Receiving this vaccine with any of the following medicines may cause an increased risk of certain side effects, but using both drugs may be the best treatment ...
In Part 1, 12 subjects with relapsed or refractory malignant mesothelioma regardless of BAP1 status will be treated and undergo pharmacokinetics (PK) blood ...
By condition, treatment or drug name ... Of Idasanutlin Monotherapy In Participants With Hydroxyurea-Resistant/Intolerant Polycythemia Vera ... TB, hepatitis ...
... of active TB: Exception: patients with a history of active TB who have documented evidence of appropriate treatment, have no history of re-exposure since ...
The purpose of this study is to evaluate the efficacy and safety of SHP647 in inducing clinical remission and endoscopic response in participants with moderate ...
The purpose of this study, as a proof-of-concept, is to investigate whether ex vivo fluorescence microscopy can provide adequate visualization of cutaneous ...
... treatment period followed by a 24-week observation period. The primary objective of this study is to assess the proportion of treatment-resistant subjects ...
The purpose of this study is to evaluate Lamprene (Clofazimine) to treat non-tuberculous mycobacterial (NTM) infections. A Study to Evaluate the QuantiFERON-TB ...
Post Approval Study For Treatment Of Drug-resistant Adult Primary FSGS Using The LIPOSORBER® LA-15 System. Scottsdale/Phoenix, Ariz., Jacksonville, Fla ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.